0.6(top 50%)
impact factor
31.7K(top 1%)
papers
201.7K(top 2%)
citations
170(top 2%)
h-index
0.8(top 50%)
extended IF
52.6K
all documents
226.8K
doc citations
361(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's and Dementia201113,319
2The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's and Dementia20117,876
3NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's and Dementia20186,501
4Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's and Dementia20115,740
5The global prevalence of dementia: A systematic review and metaanalysisAlzheimer's and Dementia20133,784
6Forecasting the global burden of Alzheimer's diseaseAlzheimer's and Dementia20072,738
7National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's diseaseAlzheimer's and Dementia20122,089
8A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's diseaseAlzheimer's and Dementia20142,006
9Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's and Dementia20111,602
10Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaAlzheimer's and Dementia20161,412
11Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspectiveAlzheimer's and Dementia20151,259
12Neuroinflammation in Alzheimer's disease: Current evidence and future directionsAlzheimer's and Dementia20161,175
13Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI)Alzheimer's and Dementia2005964
14Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenanceAlzheimer's and Dementia2020907
152012 Alzheimer's disease facts and figures Alzheimer's Association∗Alzheimer's and Dementia2012887
16Neuropsychiatric symptoms in Alzheimer's diseaseAlzheimer's and Dementia2011805
17The worldwide economic impact of dementia 2010Alzheimer's and Dementia2013804
18The worldwide costs of dementia 2015 and comparisons with 2010Alzheimer's and Dementia2017798
19MIND diet associated with reduced incidence of Alzheimer's diseaseAlzheimer's and Dementia2015725
20Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 yearsAlzheimer's and Dementia2019713
21Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control studyAlzheimer's and Dementia2015699
22The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PETAlzheimer's and Dementia2015690
23MIND diet slows cognitive decline with agingAlzheimer's and Dementia2015674
24Defining imaging biomarker cut points for brain aging and Alzheimer's diseaseAlzheimer's and Dementia2017653
25Inequalities in dementia incidence between six racial and ethnic groups over 14 yearsAlzheimer's and Dementia2016606
26The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inceptionAlzheimer's and Dementia2013568
27Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairmentAlzheimer's and Dementia2016532
28CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohortsAlzheimer's and Dementia2018526
29Understanding the impact of sex and gender in Alzheimer's disease: A call to actionAlzheimer's and Dementia2018526
30[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's diseaseAlzheimer's and Dementia2013523
31Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060)Alzheimer's and Dementia2021487
32Vascular dysfunction—The disregarded partner of Alzheimer's diseaseAlzheimer's and Dementia2019476
33Vascular contributions to cognitive impairment and dementia including Alzheimer's diseaseAlzheimer's and Dementia2015475
34The Alzheimer's Disease Neuroimaging Initiative positron emission tomography coreAlzheimer's and Dementia2010473
35Outcome over seven years of healthy adults with and without subjective cognitive impairmentAlzheimer's and Dementia2010462
36The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plansAlzheimer's and Dementia2010462
37Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationAlzheimer's and Dementia2013459
38The cost of Alzheimer's disease in China and re‐estimation of costs worldwideAlzheimer's and Dementia2018459
39Consensus classification of posterior cortical atrophyAlzheimer's and Dementia2017453
40Core candidate neurochemical and imaging biomarkers of Alzheimer's diseaseAlzheimer's and Dementia2008452
41Beneficial effects of docosahexaenoic acid on cognition in age‐related cognitive declineAlzheimer's and Dementia2010450
42Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosisAlzheimer's and Dementia2017450
43Mild cognitive impairment: Disparity of incidence and prevalence estimatesAlzheimer's and Dementia2012446
44At the interface of sensory and motor dysfunctions and Alzheimer's diseaseAlzheimer's and Dementia2015445
45The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inceptionAlzheimer's and Dementia2012439
46Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care settingAlzheimer's and Dementia2013435
47Molecular genetics of early‐onset Alzheimer's disease revisitedAlzheimer's and Dementia2016435
48Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiomeAlzheimer's and Dementia2019435
49AD dementia risk in late MCI, in early MCI, and in subjective memory impairmentAlzheimer's and Dementia2014429
50Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomographyAlzheimer's and Dementia2018427